PYC
PHYLOGICA ACHIEVES MILESTONE IN PHARMA COLLABORATION WITH JANSSEN
PERTH, AUSTRALIA: January 31, 2013 – Phylogica Ltd (ASX: PYC, XETRA: PH7), a leading Australian peptide drug discovery company, announced today the extension of its collaboration with Janssen Biotech, Inc. and its affiliates (“Janssen”) to discover, develop and commercialise new classes of peptide-drug conjugates derived from Phylogica’s Phylomer®
drug discovery platform. Phylogica has received an undisclosed payment for funding additional research associated with the extension of the collaboration.
- Forums
- ASX - Day Trading
- daytrading jan 31 afternoon
daytrading jan 31 afternoon, page-58
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, Managing Director & CEO
Charles Armstrong
Managing Director & CEO
SPONSORED BY The Market Online